TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin
Authors:
- 31 December 2012
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 53 (6) , 440-446
Abstract
Both TWIST and Wnt/β‐catenin signaling reportedly play important roles in osteosarcoma development. In the present study, we explored the regulatory effect of TWIST on β‐catenin in osteosarcoma cells and assessed how the functional interaction between TWIST and β‐catenin would impact osteosarcoma cell survival against chemotherapy agent cisplatin. Overexpression and knockdown of TWIST were respectively performed in Saos‐2 and MG‐63 osteosarcoma cells. Overexpression of TWIST in Saos‐2 cells significantly decreased the soluble β‐catenin level, phosphorylation of glycogen synthase kinase‐3β (GSK‐3β) at serine 9, the mRNA level of β‐catenin signaling target genes, and cell survival against cisplatin, which was strengthened by knocking down β‐catenin. Knockdown of TWIST in MG‐63 cells significantly increased the soluble β‐catenin level, phosphorylation of GSK‐3β at serine 9, the mRNA level of β‐catenin signaling target genes, and cell survival against cisplatin, which was reversed by knocking down β‐catenin or phosphatidylinositol 3‐kinase (PI3K) inhibitor LY294002. In conclusion, we demonstrate that TWIST decreases osteosarcoma cell survival against cisplatin by decreasing the soluble β‐catenin level through a PI3K‐dependent manner. This study provides the first evidence of a functional link between TWIST and β‐catenin signaling in osteosarcoma cells, which adds fresh insights into the molecular mechanism of osteosarcoma development.Keywords
This publication has 24 references indexed in Scilit:
- Targeted Apc;Twist Double-Mutant Mice: A New Model of Spontaneous Osteosarcoma That Mimics the Human DiseaseTranslational Oncology, 2010
- The Epidemiology of Osteosarcoma2009
- Bortezomib induces osteoblast differentiation via Wnt-independent activation of β-catenin/TCF signalingBlood, 2009
- The role of Dickkopf-1 in bone development, homeostasis, and diseaseBlood, 2009
- Involvement of MET/TWIST/APC Combination or the Potential Role of Ossification Factors in Pediatric High-Grade Osteosarcoma OncogenesisNeoplasia, 2007
- SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsEuropean Journal of Cancer, 2007
- Chemotherapy resistance in osteosarcoma: current challenges and future directionsExpert Review of Anticancer Therapy, 2006
- Wnt/β-Catenin Signaling in Mesenchymal Progenitors Controls Osteoblast and Chondrocyte Differentiation during Vertebrate SkeletogenesisDevelopmental Cell, 2005
- Mutations of the TWIST gene in the Saethre-Chotzene syndromeNature Genetics, 1997
- Dorso-ventral and rostro-caudal sequential expression of M-twist in the postimplantation murine embryoMechanisms of Development, 1995